Security key
29842P105
EUPRAXIA PHARMACEUTICALS INC. - Common Shares, no par value (EPRX)
CUSIP: 29842P105
Q2 2024 13F Holders as of 30 Jun 2024
- Type / Class
- Equity / Common Shares, no par value
- Shares outstanding
- 52,146,078
- Total 13F shares
- 1,727,190
- Share change
- +1,727,190
- Total reported value
- $4,433,025
- Price per share
- $2.58
- Number of holders
- 8
- Value change
- +$4,433,025
- Number of buys
- 8
Report period
Q2 2024
Institutions
8
Top holders
8
EPRX full security history
Newer quarter: Q3 2024
EUPRAXIA PHARMACEUTICALS INC. SEC filings
EUPRAXIA PHARMACEUTICALS INC. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 29842P105
Recent filing periods:
Top shareholders of EPRX - EUPRAXIA PHARMACEUTICALS INC. - Common Shares, no par value (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
No top shareholder records were found across 13F, 13D/G, and Forms 3/4/5 for this issuer.
Institutional Holders of EUPRAXIA PHARMACEUTICALS INC. - Common Shares, no par value (EPRX) as of Q2 2024
As of 30 Jun 2024,
EUPRAXIA PHARMACEUTICALS INC. - Common Shares, no par value (EPRX) was held by
8 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
1,727,190 shares.
The largest 8 holders included
SCOTIA CAPITAL INC., Royal Bank of Canada, BANK OF MONTREAL /CAN/, UBS Group AG, 180 WEALTH ADVISORS, LLC, JPMORGAN CHASE & CO, Federation des caisses Desjardins du Quebec, and TORONTO DOMINION BANK.
This page lists
8
institutional shareholders reporting positions in this security
for the Q2 2024 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q2 2024 vs Q4 2025 Across Filers
Q4 2025 holders
35
Q2 2024 holders
8
Holder diff
-27
| Investor | Q4 2025 Shares | Q2 2024 Shares | Share Diff | Share Chg % | Q4 2025 Value $ | Q2 2024 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.